Brief report
Efficacy of sodium glucose cotransporter 2 inhibitors as an adjunct treatment for patients with diabetes type 2
Eficacia de los inhibidores del cotransportador sodio glucosa tipo 2 como tratamiento adyuvante en pacientes con diabetes tipo 2 tratados con insulina
Pedro Pujantea,1,
, Jessica Aresa,1, Carmen Maciáb, Raúl Rodriguez Escobedoa, Edelmiro Menéndeza, Elías Delgadoa
Corresponding author
a Hospital Central de Asturias, Servicio de Endocrinología y Nutrición, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain
b Hospital San Agustín, Servicio de Endocrinología y Nutrición, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Avilés, Asturias, Spain
Read
35
Timeswas read the article
0
Total PDF
35
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 April | 1 | 0 | 1 |
| 2024 February | 1 | 0 | 1 |
| 2024 January | 1 | 0 | 1 |
| 2023 December | 1 | 0 | 1 |
| 2023 November | 1 | 0 | 1 |
| 2023 October | 1 | 0 | 1 |
| 2023 September | 3 | 0 | 3 |
| 2023 July | 1 | 0 | 1 |
| 2023 May | 1 | 0 | 1 |
| 2023 February | 1 | 0 | 1 |
| 2022 November | 2 | 0 | 2 |
| 2022 October | 3 | 0 | 3 |
| 2022 September | 4 | 0 | 4 |
| 2022 August | 3 | 0 | 3 |
| 2022 July | 1 | 0 | 1 |
| 2022 June | 2 | 0 | 2 |
| 2022 May | 2 | 0 | 2 |
| 2022 April | 2 | 0 | 2 |
| 2022 March | 3 | 0 | 3 |
| 2019 November | 1 | 0 | 1 |
Show all
